Methods of detecting a neurological condition via analysis of circulating phagocytes
The present invention features methods of monitoring or detecting a neurological or inflammatory condition in a patient. The method comprises (1) obtaining from the patient a fluid sample from outside of a brain tissue of the patient, wherein the fluid sample contains a circulating phagocyte, and (2) detecting for one or more biomarkers (e.g., a panel of biomarkers) inside the phagocyte, wherein the biomarker is associated with the respective neurological or inflammatory condition.
1. A method of detecting multiple sclerosis in a patient, the method comprises:
(a) obtaining from the patient a fluid sample from outside of a brain tissue of the patient, the fluid sample comprises a blood sample or a cerebrospinal fluid sample, the fluid sample contains a circulating phagocyte; and
(b) detecting a multiple sclerosis-associated biomarker in the phagocyte, the biomarker is a neural-specific biomarker comprising Tau, a fragment of Tau, phosphorylated Tau, hippocalcin-1, or 14-3-3 protein;
wherein detecting the biomarker in the phagocyte obtained from the fluid sample at a level higher than that of a control is indicative that the patient has multiple sclerosis.